Gregory D Waller - Net Worth and Insider Trading

Gregory D Waller Net Worth

The estimated net worth of Gregory D Waller is at least $584 dollars as of 2024-11-11. Gregory D Waller is the Director of Endologix Inc and owns about 29,340 shares of Endologix Inc (ELGXQ) stock worth over $584. Gregory D Waller is also the Director of Nuwellis Inc and owns about 0 shares of Nuwellis Inc (NUWE) stock worth over $0. Details can be seen in Gregory D Waller's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gregory D Waller has not made any transactions after 2019-11-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Gregory D Waller

Gregory D Waller Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory D Waller owns 4 companies in total, including Endologix Inc (ELGXQ) , Arcadia Biosciences Inc (RKDA) , and Nuwellis Inc (NUWE) among others .

Click here to see the complete history of Gregory D Waller’s form 4 insider trades.

Insider Ownership Summary of Gregory D Waller

Ticker	Comapny	Transaction Date	Type of Owner
ELGXQ	Endologix Inc	2020-08-12	director
RKDA	Arcadia Biosciences Inc	2017-06-07	director
NUWE	Nuwellis Inc	2023-05-19	director
		2009-10-21	director

Gregory D Waller Latest Holdings Summary

Gregory D Waller currently owns a total of 2 stocks. Among these stocks, Gregory D Waller owns 29,340 shares of Endologix Inc (ELGXQ) as of November 11, 2019, with a value of $584 and a weighting of 100%. Gregory D Waller also owns 0 shares of Nuwellis Inc (NUWE) as of August 10, 2018, with a value of $0 and a weighting of 0%.

Latest Holdings of Gregory D Waller

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ELGXQ	Endologix Inc	2019-11-11	29,340	0.02	584
NUWE	Nuwellis Inc	2018-08-10	0	2.01	0

Holding Weightings of Gregory D Waller

Gregory D Waller Form 4 Trading Tracker

According to the SEC Form 4 filings, Gregory D Waller has made a total of 0 transactions in Endologix Inc (ELGXQ) over the past 5 years. The most-recent trade in Endologix Inc is the sale of 582 shares on November 11, 2019, which brought Gregory D Waller around $1,746.

According to the SEC Form 4 filings, Gregory D Waller has made a total of 0 transactions in Nuwellis Inc (NUWE) over the past 5 years. The most-recent trade in Nuwellis Inc is the sale of 0 shares on August 10, 2018, which brought Gregory D Waller around $74.

Insider Trading History of Gregory D Waller

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gregory D Waller Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gregory D Waller Ownership Network

Ownership Network List of Gregory D Waller

No Data

Ownership Network Relation of Gregory D Waller

Gregory D Waller Owned Company Details

What does Endologix Inc do?

Who are the key executives at Endologix Inc?

Gregory D Waller is the director of Endologix Inc. Other key executives at Endologix Inc include director & CEO and Director John Onopchenko , Chief Medical Officer Matthew Thompson , and Controller and Corp Secretary Timothy Nicholas Brady .

Endologix Inc (ELGXQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Endologix Inc (ELGXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endologix Inc (ELGXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Endologix Inc (ELGXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Endologix Inc Insider Transactions

No Available Data

What does Arcadia Biosciences Inc do?

Who are the key executives at Arcadia Biosciences Inc?

Gregory D Waller is the director of Arcadia Biosciences Inc. Other key executives at Arcadia Biosciences Inc include Chief Financial Officer Thomas J. Schaefer , Chief Executive Officer Stanley Jr Jacot , and Chief Financial Officer Pamela Haley .

Arcadia Biosciences Inc (RKDA) Insider Trades Summary

Over the past 18 months, Gregory D Waller made no insider transaction in Arcadia Biosciences Inc (RKDA). Other recent insider transactions involving Arcadia Biosciences Inc (RKDA) include a net purchase of 2,049 shares made by Thomas J. Schaefer , a net purchase of 5,000 shares made by Stanley Jr Jacot , and a net purchase of 700 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Arcadia Biosciences Inc (RKDA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arcadia Biosciences Inc (RKDA) were sold and 7,749 shares were bought by its insiders, resulting in a net purchase of 7,749 shares.

Arcadia Biosciences Inc (RKDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arcadia Biosciences Inc Insider Transactions

No Available Data

What does Nuwellis Inc do?

Who are the key executives at Nuwellis Inc?

Gregory D Waller is the director of Nuwellis Inc. Other key executives at Nuwellis Inc include Chief Financial Officer Robert Benjamin Scott , Chief Commercial Officer Nestor Jr. Jaramillo , and Chief Financial Officer Lynn Larson Blake .

Nuwellis Inc (NUWE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Nuwellis Inc (NUWE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Nuwellis Inc (NUWE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Nuwellis Inc (NUWE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Nuwellis Inc Insider Transactions

No Available Data

What does Biolase Inc do?

Who are the key executives at Biolase Inc?

Gregory D Waller is the director of Biolase Inc. Other key executives at Biolase Inc include 10 percent owner Goldman Sachs Group Inc , 10 percent owner Goldman Sachs & Co. Llc , and Chief Financial Officer Jennifer Bright .

Biolase Inc (BIOLQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biolase Inc (BIOLQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biolase Inc (BIOLQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biolase Inc (BIOLQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Biolase Inc Insider Transactions

No Available Data

Gregory D Waller Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory D Waller. You might contact Gregory D Waller via mailing address: 1717 W Collins Avenue, Orange Ca 92867.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.